memantine has been researched along with rimantadine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Camins, A; Camps, P; Cortés, D; De Clercq, E; Duque, MD; Ivorra, D; Kelly, JM; López-Querol, M; Naesens, L; Pallàs, M; Prathalingam, SR; Romero, V; Sureda, FX; Vázquez, S | 1 |
| Camps, P; De Clercq, E; Duque, MD; Kelly, JM; López-Querol, M; Mallol, J; Montaner, S; Naesens, L; Prathalingam, SR; Profire, L; Sureda, FX; Vázquez, S | 1 |
| Camins, A; Camps, P; Duque, MD; Kelly, JM; López-Querol, M; Prathalingam, SR; Sureda, FX; Torres, E; Valverde, E; Vázquez, S | 1 |
| Duque, MD; Kelly, JM; López-Querol, M; Ma, C; Naesens, L; Pinto, LH; Sureda, FX; Taylor, MC; Torres, E; Vázquez, S | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kramer, MJ; Tilley, JW | 1 |
| Havel, J; Pazourek, J; Polásková, P; Reichová, N | 1 |
| Fujii, Y; Higashi, Y | 1 |
| Fujii, Y; Higashi, Y; Matsumura, H; Nakamura, S | 1 |
| Fang, F; Han, L; Ming, M; Shuangjin, C | 1 |
| Alqazzaz, M; Debaveye, S; Han, L; Lummis, SC; Lynch, JW; Price, K; Spurny, R; Thompson, AJ; Tresadern, G; Ulens, C; Villalgordo, JM | 1 |
| Leong, NJ; Mcintosh, MP; Prankerd, RJ; Shackleford, DM | 1 |
| Chen, D; Miao, H; Wu, Y; Zhao, Y | 1 |
| Bukh, J; Fahnøe, U; Galli, A; Gammeltoft, KA; Gottwein, JM; Offersgaard, A; Ramirez, S; Zhou, Y | 1 |
2 review(s) available for memantine and rimantadine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Aminoadamantane derivatives.
Topics: Amantadine; Animals; Antiviral Agents; Humans; Memantine; Nervous System Diseases; Rimantadine | 1981 |
12 other study(ies) available for memantine and rimantadine
| Article | Year |
|---|---|
Synthesis and pharmacological evaluation of several ring-contracted amantadine analogs.
Topics: Amantadine; Animals; Antiviral Agents; Cells, Cultured; Dogs; Dopamine; Influenza A virus; Inhibitory Concentration 50; Receptors, N-Methyl-D-Aspartate | 2008 |
Synthesis and pharmacological evaluation of (2-oxaadamant-1-yl)amines.
Topics: Adamantane; Amines; Animals; Antiviral Agents; Cell Culture Techniques; Receptors, N-Methyl-D-Aspartate; Trypanocidal Agents | 2009 |
New oxapolycyclic cage amines with NMDA receptor antagonist and trypanocidal activities.
Topics: Amines; Animals; Antiparkinson Agents; Cells, Cultured; Humans; Memantine; Molecular Structure; Neurons; Parkinson Disease; Rats; Receptors, N-Methyl-D-Aspartate; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis | 2010 |
Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities.
Topics: Amines; Antiviral Agents; DNA Viruses; Humans; Receptors, N-Methyl-D-Aspartate; Trypanocidal Agents; Trypanosoma brucei brucei | 2012 |
Electrophoretic behavior of adamantane derivatives possessing antiviral activity and their determination by capillary zone electrophoresis with indirect detection.
Topics: alpha-Cyclodextrins; Amantadine; Antiviral Agents; beta-Cyclodextrins; Cyclodextrins; Electric Conductivity; Electrophoresis, Capillary; Memantine; Rimantadine | 2002 |
Simultaneous determination of the binding of amantadine and its analogues to synthetic melanin by liquid chromatography after precolumn derivatization with dansyl chloride.
Topics: Amantadine; Chromatography, Liquid; Dansyl Compounds; Melanins; Memantine; Reproducibility of Results; Rimantadine | 2005 |
Simultaneous liquid chromatographic assay of amantadine and its four related compounds in phosphate-buffered saline using 4-fluoro-7-nitro-2,1,3-benzoxadiazole as a fluorescent derivatization reagent.
Topics: 4-Chloro-7-nitrobenzofurazan; Amantadine; Binding, Competitive; Calibration; Chromatography, High Pressure Liquid; Fluorescent Dyes; Humans; Memantine; Phosphates; Reproducibility of Results; Rimantadine; Sodium Chloride | 2006 |
New method for high-performance liquid chromatographic determination of amantadine and its analogues in rat plasma.
Topics: Amantadine; Animals; Antiviral Agents; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Feasibility Studies; Male; Memantine; Molecular Structure; Rats; Rats, Sprague-Dawley; Rimantadine; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Temperature; Time Factors | 2007 |
The prokaryote ligand-gated ion channel ELIC captured in a pore blocker-bound conformation by the Alzheimer's disease drug memantine.
Topics: Amino Acid Sequence; Animals; Bacterial Proteins; Crystallography, X-Ray; Dickeya chrysanthemi; Humans; Ligand-Gated Ion Channels; Memantine; Models, Molecular; Molecular Mimicry; Molecular Sequence Data; Mutation; Oocytes; Patch-Clamp Techniques; Phenylalanine; Protein Conformation; Rimantadine; Xenopus | 2014 |
The effect of intravenous sulfobutylether7 -β-cyclodextrin on the pharmacokinetics of a series of adamantane-containing compounds.
Topics: Amantadine; Animals; beta-Cyclodextrins; Drug Interactions; Erythrocytes; Injections, Intravenous; Male; Memantine; Models, Biological; Protein Binding; Rats, Sprague-Dawley; Rimantadine | 2015 |
Dispersive micro solid phase extraction of amantadine, rimantadine and memantine in chicken muscle with magnetic cation exchange polymer.
Topics: Adsorption; Amantadine; Animals; Antiviral Agents; Cations; Chickens; Chromatography, High Pressure Liquid; Dopamine Agents; Food Contamination; Limit of Detection; Magnets; Mass Spectrometry; Memantine; Muscles; Polymers; Poultry; Rimantadine; Solid Phase Extraction | 2017 |
Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro.
Topics: A549 Cells; Adenosine Monophosphate; Alanine; Amantadine; Animals; Antiviral Agents; Cell Line, Tumor; Chlorocebus aethiops; COVID-19 Drug Treatment; Denmark; Drug Repositioning; Humans; Ion Channels; Memantine; Rimantadine; SARS-CoV-2; Vero Cells | 2021 |